Most Patients Keep Weight Off After Stopping Ozempic, Real-World Study Shows
Large study of 8,000 patients reveals stopping GLP-1 drugs doesn't guarantee weight regain as many restart treatment or adopt lifestyle changes.
20 articles
Large study of 8,000 patients reveals stopping GLP-1 drugs doesn't guarantee weight regain as many restart treatment or adopt lifestyle changes.
UC Riverside scientists developed a gel that delivers continuous oxygen to chronic wounds, healing fatal injuries in diabetic mice within weeks.
A newly defined health condition linking heart, kidney, and metabolic problems affects nearly all adults, but awareness remains critically low.
Scientists discover how thin mountain air transforms red blood cells into glucose absorbers, explaining lower diabetes rates at elevation.
Historical and modern evidence suggests fasting can reverse diabetes, but sustainable dietary changes are crucial for lasting results.
New research shows extreme calorie restriction alone matches bariatric surgery's diabetes reversal benefits without surgical risks.
New research shows diabetes and weight-loss medications slow alcohol absorption, making people feel less intoxicated and potentially reducing drinking.
WHO-commissioned reviews find Ozempic and similar drugs deliver up to 16% weight loss, but long-term safety data remains limited.
New research shows ketogenic diet helps normalize blood sugar and dramatically improves muscle response to exercise in mice.
Experimental diabetes drug IC7Fc reduces cholesterol and artery plaque buildup, offering cardiovascular benefits even without weight loss.
New research shows blood sugar can normalize without losing weight by shifting harmful belly fat to healthier locations under the skin.
New rare sugar sweetener may reduce body fat and blood sugar, but research shows mixed results and potential digestive issues.
Three NIH-funded studies this week tackle metabolic decline, cardiac risk, and brain tumors โ all with aging implications.
New AI-powered blood test analyzes DNA fragments to catch liver fibrosis and cirrhosis in early, treatable stages before damage becomes irreversible.
New research identifies LRG1 protein as early trigger of diabetic retinopathy, opening door to prevention-based treatments.
Three new NIH-funded findings tackle metabolic aging, cardiovascular risk, and a surprising hormonal brake on brain tumors.
New research exposes hidden psychological costs of weight loss surgery, including increased suicide risk and lasting mental health challenges.
New research reveals how gut cells communicate with your brain to shut down appetite during infection through a two-phase signaling process.
New research reveals how gut cells communicate with your brain to shut down appetite during infection through a two-phase signaling process.
Yale researchers solved how coenzyme A from vitamin B5 enters mitochondria, unlocking new insights into metabolism and disease prevention.